|
1
|
Hattner R, Epker BN and Frost HM:
Suggested sequential mode of control of changes in cell behaviour
in adult bone remodelling. Nature. 206:489–490. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li C, Shi C, Kim J, Chen Y, Ni S, Jiang L,
Zheng C, Li D, Hou J, Taichman RS and Sun H: Erythropoietin
promotes bone formation through EphrinB2/EphB4 signaling. J Dent
Res. 94:455–463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takayanagi H: Osteoimmunology: Shared
mechanisms and crosstalk between the immune and bone systems. Nat
Rev Immunol. 7:292–304. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taubman MA and Kawai T: Involvement of
T-lymphocytes in periodontal disease and in direct and indirect
induction of bone resorption. Crit Rev Oral Biol Med. 12:125–135.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dequeker J, Maenaut K, Verwilghen J and
Westhovens R: Osteoporosis in rheumatoid arthritis. Clin Exp
Rheumatol. 12(13 Suppl): S21–S26. 1995.
|
|
6
|
Kotake S, Udagawa N, Hakoda M, Mogi M,
Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, et al:
Activated human T cells directly induce osteoclastogenesis from
human monocytes: Possible role of T cells in bone destruction in
rheumatoid arthritis patients. Arthritis Rheum. 44:1003–1012. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harrison DE, Strong R, Sharp ZD, Nelson
JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter
CS, et al: Rapamycin fed late in life extends lifespan in
genetically heterogeneous mice. Nature. 460:392–395.
2009.PubMed/NCBI
|
|
8
|
Guba M, von Breitenbuch P, Steinbauer M,
Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S,
Anthuber M, et al: Rapamycin inhibits primary and metastatic tumor
growth by antiangiogenesis: Involvement of vascular endothelial
growth factor. Nat Med. 8:128–135. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng N, Ding X and Jahan R: Low
concentration of rapamycin inhibits hemangioma endothelial cell
proliferation, migration, and vascular tumor formation in mice.
Curr Ther Res Clin Exp. 76:99–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cho HJ, Park J, Lee HW, Lee YS and Kim JB:
Regulation of adipocyte differentiation and insulin action with
rapamycin. Biochem Biophys Res Commun. 321:942–948. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Antonarakis ES, Carducci MA and
Eisenberger MA: Novel targeted therapeutics for metastatic
castration-resistant prostate cancer. Cancer Lett. 291:1–13. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sarbassov DD, Ali SM, Sengupta S, Sheen
JH, Hsu PP, Bagley AF, Markhard AL and Sabatini DM: Prolonged
rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell.
22:159–168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Q and Guan KL: Expanding mTOR
signaling. Cell Res. 17:666–681. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lam J, Takeshita S, Barker JE, Kanagawa O,
Ross FP and Teitelbaum SL: TNF-alpha induces osteoclastogenesis by
direct stimulation of macrophages exposed to permissive levels of
RANK ligand. J Clin Invest. 106:1481–1488. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fielhaber JA, Carroll SF, Dydensborg AB,
Shourian M, Triantafillopoulos A, Harel S, Hussain SN, Bouchard M,
Qureshi ST and Kristof AS: Inhibition of mammalian target of
rapamycin augments lipopolysaccharide-induced lung injury and
apoptosis. J Immunol. 188:4535–4542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tulek B, Kiyan E, Toy H, Kiyici A, Narin C
and Suerdem M: Anti-inflammatory and anti-fibrotic effects of
sirolimus on bleomycin-induced pulmonary fibrosis in rats. Clin
Invest Med. 34:E3412011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singha UK, Jiang Y, Yu S, Luo M, Lu Y,
Zhang J and Xiao G: Rapamycin inhibits osteoblast proliferation and
differentiation in MC3T3-E1 cells and primary mouse bone marrow
stromal cells. J Cell Biochem. 103:434–446. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shui C, Riggs BL and Khosla S: The
immunosuppressant rapamycin, alone or with transforming growth
factor-beta, enhances osteoclast differentiation of RAW264.7
monocyte-macrophage cells in the presence of RANK-ligand. Calcif
Tissue Int. 71:437–446. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Phornphutkul C, Lee M, Voigt C, Wu KY,
Ehrlich MG, Gruppuso PA and Chen Q: The effect of rapamycin on bone
growth in rabbits. J Orthop Res. 27:1157–1161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Viñals F, López-Rovira T, Rosa JL and
Ventura V: Inhibition of PI3K/p70 S6K and p38 MAPK cascades
increases osteoblastic differentiation induced by BMP-2. FEBS Lett.
510:99–104. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee KW, Yook JY, Son MY, Kim MJ, Koo DB,
Han YM and Cho YS: Rapamycin promotes the osteoblastic
differentiation of human embryonic stem cells by blocking the mTOR
pathway and stimulating the BMP/Smad pathway. Stem Cells Dev.
19:557–568. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lian JB, Javed A, Zaidi SK, Lengner C,
Montecino M, van Wijnen AJ, Stein JL and Stein GS: Regulatory
controls for osteoblast growth and differentiation: Role of
Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr. 14:1–41. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Owen TA, Aronow M, Shalhoub V, Barone LM,
Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB and Stein
GS: Progressive development of the rat osteoblast phenotype in
vitro: Reciprocal relationships in expression of genes associated
with osteoblast proliferation and differentiation during formation
of the bone extracellular matrix. J Cell Physiol. 143:420–430.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stricker S, Fundele R, Vortkamp A and
Mundlos S: Role of Runx genes in chondrocyte differentiation. Dev
Biol. 245:95–108. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mohamadnia AR, Shahbazkia HR, Sharifi S
and Shafael I: Bone-specific alkaline phosphatase as a good
indicator of bone formation in sheepdogs. Comp Clin Path.
16:265–270. 2007. View Article : Google Scholar
|
|
26
|
Matsubara T, Kida K, Yamaguchi A, Hata K,
Ichida F, Meguro H, Aburatani H, Nishimura R and Yoneda T: BMP2
regulates Osterix through Msx2 and Runx2 during osteoblast
differentiation. J Biol Chem. 283:29119–29125. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nishio Y, Dong Y, Paris M, O'Keefe RJ,
Schwarz EM and Drissi H: Runx2-mediated regulation of the zinc
finger Osterix/Sp7 gene. Gene. 372:62–70. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Elsubeihi ES and Heersche JN: Quantitative
assessment of post-extraction healing and alveolar ridge
remodelling of the mandible in female rats. Arch Oral Biol.
49:401–412. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sanchez CP and He YZ: Bone growth during
rapamycin therapy in young rats. BMC Pediatr. 9:32009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun H, Kim JK, Mortensen R, Mutyaba LP,
Hankenson KD and Krebsbach PH: Osteoblast-targeted suppression of
PPARγ increases osteogenesis through activation of mTOR signaling.
Stem Cells. 31:2183–2192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Y, Yi XD and Li CD: Suppression of
mTOR signaling pathway promotes bone marrow mesenchymal stem cells
differentiation into osteoblast in degenerative scoliosis: In vivo
and in vitro. Mol Biol Rep. 44:129–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Van der Bruggen T, Nijenhuis S, van Raaij
E, Verhoef J and van Asbeck BS: Lipopolysaccharide-induced tumor
necrosis factor alpha production by human monocytes involves the
raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect Immun. 67:3824–3829.
1999.PubMed/NCBI
|
|
33
|
Fisher CJ Jr, Agosti JM, Opal SM, Lowry
SF, Balk RA, Sadoff JC, Abraham E, Schein RM and Benjamin E:
Treatment of septic shock with the tumor necrosis factor receptor:
Fc fusion protein. The soluble TNF receptor sepsis study group. N
Engl J Med. 334:1697–1702. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Glauser MP, Zanetti G, Baumgartner JD and
Cohen J: Septic shock: Pathogenesis. Lancet. 338:732–736. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sweet MJ and Hume DA: Endotoxin signal
transduction in macrophages. J Leukoc Biol. 60:8–26.
1996.PubMed/NCBI
|
|
36
|
Pacifici R, Brown C, Puscheck E, Friedrich
E, Slatopolsky E, Maggio D, McCracken R and Avioli LV: Effect of
surgical menopause and estrogen replacement on cytokine release
from human blood mononuclear cells. Proc Natl Acad Sci USA. 88:pp.
5134–5138. 1991; View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Manolagas SC, Bellido T and Jilka RL: New
insights into the cellular, biochemical, and molecular basis of
postmenopausal and senile osteoporosis: Roles of IL-6 and gp130.
Int J Immunopharmacol. 17:109–116. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hofbauer LC, Lacey DL, Dunstan CR,
Spelsberg TC, Riggs BL and Khosla S: Interleukin-1beta and tumor
necrosis factor-alpha, but not interleukin-6, stimulate
osteoprotegerin ligand gene expression in human osteoblastic cells.
Bone. 25:255–259. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wei S, Kitaura H, Zhou P, Ross FP and
Teitelbaum SL: IL-1 mediates TNF-induced osteoclastogenesis. J Clin
Invest. 115:282–290. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weitzmann MN, Roggia C, Toraldo G,
Weitzmann L and Pacifici R: Increased production of IL-7 uncouples
bone formation from bone resorption during estrogen deficiency. J
Clin Invest. 110:1643–1650. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Krajewski AC, Biessei J, Kunze M, Maersch
S, Perabo L and Noack MJ: Influence of lipopolysaccharide and
interleukin-6 on RANKL and OPG expression and release in human
periodontal ligament cells. APMIS. 117:746–754. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Powell N, Till S, Bungre J and Corrigan C:
The immunomodulatory drugs cyclosporin A, mycophenolate mofetil,
and sirolimus (rapamycin) inhibit allergen-induced proliferation
and IL-5 production by PBMCs from atopic asthmatic patients. J
Allergy Clin Immunol. 108:915–917. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Luo D, Ren H, Li T, Lian K and Lin D:
Rapamycin reduces severity of senile osteoporosis by activating
osteocyte autophagy. Osteoporos Int. 27:1093–1101. 2016. View Article : Google Scholar : PubMed/NCBI
|
